Quality of Prostate Cancer Treatment Information on Cancer Center Websites

Por Dulaney, Caleb, Barrett, Olivia Claire, Rais-Bahrami, Soroush, Wakefield, Daniel, Fiveash, John, Dobelbower, Michael
Publicado no Cureus (2016)

Optimal Planning Target Volume Margins for Elective Pelvic Lymphatic Radiotherapy in High-Risk Prostate Cancer Patients

Por Hinton, Benjamin K., Fiveash, John B., Wu, Xingen, Dobelbower, Michael C., Kim, Robert Y., Jacob, Rojymon
Publicado em 2013

Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide

Por Gebhardt, Brian J, Dobelbower, Michael C, Ennis, William H, Bag, Asim K, Markert, James M, Fiveash, John B
Publicado em 2014

Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer

Por Nowsheen, Somaira, Bonner, James A., LoBuglio, Albert F., Trummell, Hoa, Whitley, Alexander C., Dobelbower, Michael C., Yang, Eddy S.
Publicado em 2011

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry

Por McDonald, Andrew M., Bishop, Justin M., Jacob, Rojymon, Dobelbower, Michael C., Kim, Robert Y., Yang, Eddy S., Smith, Heather, Wu, Xingen, Fiveash, John B.
Publicado em 2012

Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per...

Por Prendergast, Brendan M, Dobelbower, Michael C, Bonner, James A, Popple, Richard A, Baden, Craig J, Minnich, Douglas J, Cerfolio, Robert J, Spencer, Sharon A, Fiveash, John B
Publicado em 2013

Comparison of Plan Quality and Delivery Time between Volumetric Arc Therapy (RapidArc) and Gamma Knife Radiosurgery for Multiple Cranial Metastases

Por Thomas, Evan M, Popple, Richard A, Wu, Xingen, Clark, Grant M, Markert, James M, Guthrie, Barton L, Yuan, Yu, Dobelbower, Michael C, Spencer, Sharon A, Fiveash, John B
Publicado em 2014

A Phase III trial of 2 Years of Androgen Suppression (AS) and Radiation Therapy (RT) with or without Adjuvant Chemotherapy (CT) for High-Risk Prostate Cancer: Final Results of Radi...

Por Rosenthal, Seth A., Hunt, Daniel, Sartor, A. Oliver, Pienta, Kenneth J., Gomella, Leonard, Grignon, David, Rajan, Raghu, Kerlin, Kevin J., Jones, Christopher U., Dobelbower, Michael, Shipley, William U., Zeitzer, Kenneth, Hamstra, Daniel A., Donavanik, Viroon, Rotman, Marvin, Hartford, Alan C., Michalski, Jeffrey, Seider, Michael, Kim, Harold, Kuban, Deborah A., Moughan, Jennifer, Sandler, Howard
Publicado no Int J Radiat Oncol Biol Phys (2015)